Answer
New or worsening inflammatory bowel disease has been reported with IL-17 inhibitors. Brodalumab is contraindicated in active Crohn's disease and is not recommended in inflammatory bowel disease.
Sources for this answer
- Kyntheum 210 mg Solution for Injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.